Αναζήτηση

σε πρόσθεσε στο Networking

2026-04-30 05:19:51 -

Ultomiris Market Trends, Growth Drivers, and Future Outlook (2026–2033)

Ultomiris Drug (ravulizumab) Market is a long-acting monoclonal antibody developed to treat rare complement-mediated disorders. As a C5 complement inhibitor, it plays a critical role in managing diseases such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder...

0 Σχόλια 0 Μοιράστηκε 28 Views 0 Προεπισκόπηση